ErbB2 overexpression on occult metastatic cells in bone marrow predicts poor clinical outcome of stage I-III breast cancer patients.
Year: 2001
Type: article
Study design: Observational Study
Source: PubMed
Authors: S Braun, G Schlimok, I Heumos, G Schaller, L Riethdorf, G Riethmüller, K Pantel
Institutions: TUM Klinikum, Technical University of Munich
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2157040071
